Literature DB >> 24059837

I2-mediated oxidative C-O bond formation for the synthesis of 1,3,4-oxadiazoles from aldehydes and hydrazides.

Wenquan Yu1, Gang Huang, Yueteng Zhang, Hongxu Liu, Lihong Dong, Xuejun Yu, Yujiang Li, Junbiao Chang.   

Abstract

A practical and transition-metal-free oxidative cyclization of acylhydrazones into 1,3,4-oxadiazoles has been developed by employing stoichiometric molecular iodine in the presence of potassium carbonate. The conditions of this cyclization reaction also work well with crude acylhydrazone substrates obtained from the condensation of aldehydes and hydrazides. A series of symmetrical and asymmetrical 2,5-disubstituted (aryl, alkyl, and/or vinyl) 1,3,4-oxadiazoles can be conveniently generated in an efficient and scalable fashion.

Entities:  

Year:  2013        PMID: 24059837     DOI: 10.1021/jo401751h

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  12 in total

1.  Selective Janus Kinase 2 (JAK2) Pseudokinase Ligands with a Diaminotriazole Core.

Authors:  Maria-Elena Liosi; Stefan G Krimmer; Ana S Newton; Thomas K Dawson; David E Puleo; Kara J Cutrona; Yoshihisa Suzuki; Joseph Schlessinger; William L Jorgensen
Journal:  J Med Chem       Date:  2020-05-08       Impact factor: 7.446

2.  Ultrasound-assisted, low-solvent and acid/base-free synthesis of 5-substituted 1,3,4-oxadiazole-2-thiols as potent antimicrobial and antioxidant agents.

Authors:  Elahe Yarmohammadi; Hamid Beyzaei; Reza Aryan; Ashraf Moradi
Journal:  Mol Divers       Date:  2020-08-08       Impact factor: 2.943

3.  5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study.

Authors:  Václav Pflégr; Šárka Štěpánková; Katarína Svrčková; Markéta Švarcová; Jarmila Vinšová; Martin Krátký
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-25

4.  Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation.

Authors:  Zhiqing Liu; Bing Tian; Haiying Chen; Pingyuan Wang; Allan R Brasier; Jia Zhou
Journal:  Eur J Med Chem       Date:  2018-04-03       Impact factor: 6.514

5.  The Structural and Magnetic Properties of FeII and CoII Complexes with 2-(furan-2-yl)-5-pyridin-2-yl-1,3,4-oxadiazole.

Authors:  Pavel Zoufalý; Erik Čižmár; Juraj Kuchár; Radovan Herchel
Journal:  Molecules       Date:  2020-01-09       Impact factor: 4.411

6.  Flow synthesis of oxadiazoles coupled with sequential in-line extraction and chromatography.

Authors:  Kian Donnelly; Marcus Baumann
Journal:  Beilstein J Org Chem       Date:  2022-02-25       Impact factor: 2.883

7.  Iodine-DMSO mediated conversion of N-arylcyanothioformamides to N-arylcyanoformamides and the unexpected formation of 2-cyanobenzothiazoles.

Authors:  Ziad Moussa; Zaher M A Judeh; Ahmed Alzamly; Saleh A Ahmed; Harbi Tomah Al-Masri; Bassam Al-Hindawi; Faisal Rasool; Sara Saada
Journal:  RSC Adv       Date:  2022-02-21       Impact factor: 3.361

8.  Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis, in vitro evaluation, and molecular docking studies.

Authors:  Asma Bukhari; Humaira Nadeem; Muhammad Imran; Syed Aun Muhammad
Journal:  Iran J Basic Med Sci       Date:  2021-12       Impact factor: 2.699

9.  Reliable Functionalization of 5,6-Fused Bicyclic N-Heterocycles Pyrazolopyrimidines and Imidazopyridazines via Zinc and Magnesium Organometallics.

Authors:  Saroj Kumar Rout; Agonist Kastrati; Harish Jangra; Kuno Schwärzer; Alisa S Sunagatullina; Maximilien Garny; Fabio Lima; Cara E Brocklehurst; Konstantin Karaghiosoff; Hendrik Zipse; Paul Knochel
Journal:  Chemistry       Date:  2022-05-11       Impact factor: 5.020

10.  Acceptor Derivatization of the 4CzIPN TADF System: Color Tuning and Introduction of Functional Groups.

Authors:  Fabian Hundemer; Lorenz Graf von Reventlow; Céline Leonhardt; Mika Polamo; Martin Nieger; Stefan M Seifermann; Alexander Colsmann; Stefan Bräse
Journal:  ChemistryOpen       Date:  2019-12-13       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.